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The NetherlandsArticles attracting a large number of citations are regarded
by many as high impact or “classic” contributions. Although
limitations exist (regarding the use of citation counts to
identify the most influential articles in vascular surgery),
the article by Naylor et al.1 must be considered a classic.
Patients with significant carotid disease face an
increased risk of stroke during CABG. However, because of
the risk of stroke associated with carotid endarterectomy
(CEA) and the multitude of pathophysiological mechanisms
responsible for post-CABG stroke, the role of prophylactic
CEA is still of uncertain value. The unique importance of
this review was that the authors approached the debate in
an alternative way. Until then, most studies on prophylactic
CEA hypothesized about the optimal order of procedures
(synchronous/staged/reverse staged CEA). Instead, the
authors focused on the actual role of carotid revasculari-
zation (as a potential cause of post-CABG stroke) and then
questioned whether prophylactic carotid intervention could
ever really impact on peri-operative stroke prevention.
It is first important to note that this review focused on
30-day outcomes and did not inform the debate about the
potential benefits of prophylactic CEA (in terms of late
stroke prevention) in patients scheduled for CABG. Their
main findings were that, at the very most, only 40% of post-
CABG strokes could be attributable to carotid disease and
at least 50% of stroke sufferers did not have any significant
carotid disease at all. They then provided five data-
supported recommendations for future research with
emphasis on the need to report the laterality of any stroke,
the status of both carotids, and the timing of stroke onset
(which is still of high interest).
After CEA, it is usually possible to determine the most
likely cause of any procedure related stroke.2 SimilarDOI of original article: 10.1053/ejvs.2002.1609.
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doi:10.1016/j.ejvs.2011.06.033analyses are, however, difficult following CABG, largely
because there are no reliable cerebral monitoring or quality
control techniques for diagnosing stroke during CABG.
Furthermore, the numbers of mechanisms of stroke after
CABG are much greater than following CEA. Thirteen of the
59 series in Naylor’s review documented the timing of 484
strokes following 36,797 CABGs. A relative minority of
strokes (38%) occurred within 24 h of surgery, while the
majority happened at some postoperative moment, usually
within the first seven days. In understanding the main
causes of post-CABG stroke, intra operative hypoperfusion
and microembolization still remain important mechanisms,
but the majority cannot be simply ascribed to some adverse
intra operative event.
The ISI web of knowledge and other electronic databases
cite 12 further publications from the Leicester group
regarding the management of patients with concurrent
carotid and cardiac disease, confirming the excellent line of
research over the years. Interestingly, there have been over
40 other contemporary papers describing surgical outcomes
in patients with cardiac and carotid disease since Naylor’s
paper was published, suggesting that research interests in
this subject are still heavily influenced by the results of
staged/synchronous interventions, rather than addressing
the five research recommendations proposed by Naylor (i.e.
to determine who really does benefit from prophylactic
carotid revascularization?).
Some have suggested that carotid artery stenting (CAS)
may become a safer and preferred intervention for patients
with carotid disease who require CABG.3 However, simply
showing that CAS can be performed with an acceptable
complication rate is not the key issue. First, it has to be
proven that the combination of CAS and CABG has a signif-
icantly lower stroke/death rate than by performing CABG
alone (i.e. leaving the asymptomatic carotid artery
untreated). Until then, any revascularization before CABG
is unwarranted because it exposes patients to the risks of
peri-operative stroke and myocardial infarction twice,d by Elsevier Ltd. All rights reserved.
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more, contemporary studies have now shown that the risk
of stroke in asymptomatic patients with a unilateral
70e99% stenosis undergoing isolated CABG is extremely
low.4 The overall risk of stroke after CABG is about 2% and
after CABG plus either staged or synchronous CEA or CAS
about 9% and these figures have probably not changed over
the last decade. Attempts to set-up a CEA-CABG trial have
failed so far. Since National and international guidelines
still provide no consensus, the management of patients
with concurrent carotid and cardiac disease remains
enduringly controversial.
In Utrecht (prior to this review being published), our
policy was to perform carotid revascularization in patients
with concomitant carotid and coronary disease. Following
the report, our policy changed and patients now undergo
their cardiac procedure without carotid revascularization,
unless the patient presents with a symptomatic carotid
stenosis or contralateral occlusion. The authors have taught
the world that the presence of coexistent carotid disease inpatients scheduled for CABG is not sufficient to warrant
routine prophylactic carotid revascularization.
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